Cilostazol - Cilostazol
Navigation: NDC > Supplier starting with: B > BRECKENRIDGE PHARMACEUTICAL, INC.| Field | Value |
|---|---|
| NDC Code: | 51991-168 |
| Proprietary Name: | Cilostazol |
| Suffix: | |
| Non-Proprietary Name: | Cilostazol |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 28-09-2009 |
| Category Name: | ANDA |
| Application Number: | ANDA077708 |
| Labeler: | BRECKENRIDGE PHARMACEUTICAL, INC. |
| Substance Name: | CILOSTAZOL |
| Active Numerator Strength: | 100 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
| DEA Schedule: |